Akero Clinical Study Site

Seoul, Seoul Teugbyeolsi 04763

1 studies enrolling now · 2 studies all time

What they study most

MASH - Metabolic Dysfunction-Associated Steatohepatitis, NAFLD/MASLD, NASH - Nonalcoholic Steatohepatitis, NASH/MASH

Studies at this site

• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH — Recruiting now
• A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Running, not enrolling